Development, Vol 119, Issue 3 841-854, Copyright © 1993 by Company of Biologists

JOURNAL ARTICLES

Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development

G David, XM Bai, B Van der Schueren, P Marynen, JJ Cassiman and H Van den Berghe
Center for Human Genetics, University of Leuven, Belgium.

Fibroglycan (syndecan-2) is a member of a family of cell surface heparan sulfate proteoglycans that interact with adhesion molecules, growth factors and a variety of other effector systems that support the shaping, maintenance and repair of an organism. To investigate this apparent redundancy of proteoglycans at the cell surface, we have studied the expression of fibroglycan in the mouse embryo and compared this expression with that of syndecan-1. The characterisation of mouse embryo cDNA clones that crosshybridized to human fibroglycan-cDNA predicted that murine and human fibroglycan were highly similar in structure. Consistently, the analysis of transfectant cells, murine cell lines and embryo extracts indicated that the murine proteoglycan reacted specifically with monoclonal antibody 10H4 developed against the human protein. Fibroglycan, as detected by monoclonal antibody 10H4 in sections of embryonic tissues, occurred exclusively on mesenchymal cells that represented the putative precursors of the hard and connective tissue cells. No fibroglycan was detected in epithelia or in muscle cells. Areas where fibroglycan was particularly abundant were sites of high morphogenetic activity where intense cell-cell and cell-matrix interactions are known to occur (e.g. the epithelial-mesenchymal interfaces, the prechondrogenic and preosteogenic mesenchymal condensations). The expression of fibroglycan was weak in the early embryo, culminated during the morphogenetic phase and at the moment of cell lineage differentiation, and persisted in the perichondrium, periosteum and connective tissue cells. Syndecan-1, in contrast, was primarily detected in epithelia, and transiently in some mesenchymal cells, with mesenchymal localisations that did not or only partially overlap with those of fibroglycan. In situ hybridization analyses confirmed these expression patterns at the transcriptional level, identifying mesenchymal cells as the major source of fibroglycan production. These data indicate that the expression of fibroglycan occurs along unique and developmentally regulated patterns, and suggest that fibroglycan and syndecan-1 may have distinctive functions during tissue morphogenesis and differentiation.

This article has been cited by other articles:

				S. Munesue, Y. Yoshitomi, Y. Kusano, Y. Koyama, A. Nishiyama, H. Nakanishi, K. Miyazaki, T. Ishimaru, S. Miyaura, M. Okayama, et al. A Novel Function of Syndecan-2, Suppression of Matrix Metalloproteinase-2 Activation, Which Causes Suppression of Metastasis J. Biol. Chem., September 21, 2007; 282(38): 28164 - 28174. [Abstract] [Full Text] [PDF]

				E. Koyama, B. Young, M. Nagayama, Y. Shibukawa, M. Enomoto-Iwamoto, M. Iwamoto, Y. Maeda, B. Lanske, B. Song, R. Serra, et al. Conditional Kif3a ablation causes abnormal hedgehog signaling topography, growth plate dysfunction, and excessive bone and cartilage formation during mouse skeletogenesis Development, June 1, 2007; 134(11): 2159 - 2169. [Abstract] [Full Text] [PDF]

				A. Orosco, O. Fromigue, C. Bazille, N. Entz-Werle, P. Levillain, P. J. Marie, and D. Modrowski Syndecan-2 Affects the Basal and Chemotherapy-Induced Apoptosis in Osteosarcoma Cancer Res., April 15, 2007; 67(8): 3708 - 3715. [Abstract] [Full Text] [PDF]

				Y. Chen, X. Shi-wen, J. van Beek, L. Kennedy, M. McLeod, E. A. Renzoni, G. Bou-Gharios, S. Wilcox-Adelman, P. F. Goetinck, M. Eastwood, et al. Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-{beta}/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERK: Insights into Pathological Scarring in Chronic Fibrotic Disease Am. J. Pathol., December 1, 2005; 167(6): 1699 - 1711. [Abstract] [Full Text] [PDF]

				H. Park, I. Han, H. J. Kwon, and E.-S. Oh Focal Adhesion Kinase Regulates Syndecan-2-Mediated Tumorigenic Activity of HT1080 Fibrosarcoma Cells Cancer Res., November 1, 2005; 65(21): 9899 - 9905. [Abstract] [Full Text] [PDF]

				R. Clarijs, M. van Dijk, D. J. Ruiter, and R. M. W. de Waal Functional and Morphologic Analysis of the Fluid-Conducting Meshwork in Xenografted Cutaneous and Primary Uveal Melanoma Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3013 - 3020. [Abstract] [Full Text] [PDF]

				Y. Chen, D. Lasaitiene, B. G. Gabrielsson, L. M.S. Carlsson, H. Billig, B. Carlsson, N. Marcussen, X.-F. Sun, and P. Friberg Neonatal Losartan Treatment Suppresses Renal Expression of Molecules Involved in Cell-Cell and Cell-Matrix Interactions J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1232 - 1243. [Abstract] [Full Text] [PDF]

				E. Chen, S. Hermanson, and S. C. Ekker Syndecan-2 is essential for angiogenic sprouting during zebrafish development Blood, March 1, 2004; 103(5): 1710 - 1719. [Abstract] [Full Text] [PDF]

				Y. Kusano, Y. Yoshitomi, S. Munesue, M. Okayama, and K. Oguri Cooperation of Syndecan-2 and Syndecan-4 among Cell Surface Heparan Sulfate Proteoglycans in the Actin Cytoskeletal Organization of Lewis Lung Carcinoma Cells J. Biochem., January 1, 2004; 135(1): 129 - 137. [Abstract] [Full Text] [PDF]

				K. Schumacher, R. Strehl, U. de Vries, H. J. Groene, and W. W. Minuth SBA-Positive Fibers between the CD Ampulla, Mesenchyme, and Renal Capsule J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2446 - 2453. [Abstract] [Full Text] [PDF]

				C. E. Bandtlow and D. R. Zimmermann Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins Physiol Rev, October 1, 2000; 80(4): 1267 - 1290. [Abstract] [Full Text] [PDF]

				J. Kishibe, S. Yamada, Y. Okada, J. Sato, A. Ito, K. Miyazaki, and K. Sugahara Structural Requirements of Heparan Sulfate for the Binding to the Tumor-derived Adhesion Factor/Angiomodulin That Induces Cord-like Structures to ECV-304 Human Carcinoma Cells J. Biol. Chem., May 12, 2000; 275(20): 15321 - 15329. [Abstract] [Full Text] [PDF]

				D. Modrowski, M. Basle, A. Lomri, and P. J. Marie Syndecan-2 Is Involved in the Mitogenic Activity and Signaling of Granulocyte-Macrophage Colony-stimulating Factor in Osteoblasts J. Biol. Chem., March 24, 2000; 275(13): 9178 - 9185. [Abstract] [Full Text] [PDF]

				C. Klass, J. Couchman, and A Woods Control of extracellular matrix assembly by syndecan-2 proteoglycan J. Cell Sci., January 2, 2000; 113(3): 493 - 506. [Abstract] [PDF]

				M. M. Verbeek, I. Otte-Holler, J. van den Born, L. P. W. J. van den Heuvel, G. David, P. Wesseling, and R. M. W. de Waal Agrin Is a Major Heparan Sulfate Proteoglycan Accumulating in Alzheimer’s Disease Brain Am. J. Pathol., December 1, 1999; 155(6): 2115 - 2125. [Abstract] [Full Text] [PDF]

				M. Veugelers, B. De Cat, H. Ceulemans, A.-M. Bruystens, C. Coomans, J. Durr, J. Vermeesch, P. Marynen, and G. David Glypican-6, a New Member of the Glypican Family of Cell Surface Heparan Sulfate Proteoglycans J. Biol. Chem., September 17, 1999; 274(38): 26968 - 26977. [Abstract] [Full Text] [PDF]

				S. Clasper, S. Vekemans, M. Fiore, M. Plebanski, P. Wordsworth, G. David, and D. G. Jackson Inducible Expression of the Cell Surface Heparan Sulfate Proteoglycan Syndecan-2 (Fibroglycan) on Human Activated Macrophages Can Regulate Fibroblast Growth Factor Action J. Biol. Chem., August 20, 1999; 274(34): 24113 - 24123. [Abstract] [Full Text] [PDF]

				M. Romaris, C. Coomans, H. Ceulemans, A.-M. Bruystens, S. Vekemans, and G. David Molecular Polymorphism of the Syndecans. IDENTIFICATION OF A HYPO-GLYCANATED MURINE SYNDECAN-1 SPLICE VARIANT J. Biol. Chem., June 25, 1999; 274(26): 18667 - 18674. [Abstract] [Full Text] [PDF]

				M.M. French, S.E. Smith, K. Akanbi, T. Sanford, J. Hecht, M.C. Farach-Carson, and D.D. Carson Expression of the Heparan Sulfate Proteoglycan, Perlecan, during Mouse Embryogenesis and Perlecan Chondrogenic Activity In Vitro J. Cell Biol., May 31, 1999; 145(5): 1103 - 1115. [Abstract] [Full Text] [PDF]

				I. M. Ethell and Y. Yamaguchi Cell Surface Heparan Sulfate Proteoglycan Syndecan-2 Induces the Maturation of Dendritic Spines in Rat Hippocampal Neurons J. Cell Biol., February 8, 1999; 144(3): 575 - 586. [Abstract] [Full Text] [PDF]

				S. F. Penc, B. Pomahac, T. Winkler, R. A. Dorschner, E. Eriksson, M. Herndon, and R. L. Gallo Dermatan Sulfate Released after Injury Is a Potent Promoter of Fibroblast Growth Factor-2 Function J. Biol. Chem., October 23, 1998; 273(43): 28116 - 28121. [Abstract] [Full Text] [PDF]

				A. J. McFall and A. C. Rapraeger Characterization of the High Affinity Cell-binding Domain in the Cell Surface Proteoglycan Syndecan-4 J. Biol. Chem., October 23, 1998; 273(43): 28270 - 28276. [Abstract] [Full Text] [PDF]

				L. Sherman, D. Wainwright, H. Ponta, and P. Herrlich A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth Genes & Dev., April 1, 1998; 12(7): 1058 - 1071. [Abstract] [Full Text]

				A. J. McFall and A. C. Rapraeger Identification of an Adhesion Site within the Syndecan-4 Extracellular Protein Domain J. Biol. Chem., May 16, 1997; 272(20): 12901 - 12904. [Abstract] [Full Text] [PDF]

				L Schuger, G. Johnson, K Gilbride, G. Plowman, and R Mandel Amphiregulin in lung branching morphogenesis: interaction with heparan sulfate proteoglycan modulates cell proliferation Development, January 6, 1996; 122(6): 1759 - 1767. [Abstract] [PDF]

				M. J. Stanley, B. F. Liebersbach, W. Liu, D. J. Anhalt, and R. D. Sanderson Heparan Sulfate-mediated Cell Aggregation J. Biol. Chem., March 10, 1995; 270(10): 5077 - 5083. [Abstract] [Full Text] [PDF]